Schrödinger, Inc. (SDGR)
Oxford Ledge is still expanding full research coverage of SDGR. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company licenses computational drug discovery software globally and develops its own drug candidates through partnerships and internal programs.
SEC filings
- 8-K Regulation FD disclosure 2026-06-29
- 8-K Departure/election of directors or officers; Shareholder vote results; Financial statements and exhibits 2026-06-23
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-06-08
- 8-K Departure/election of directors or officers; Regulation FD disclosure 2026-05-20
- 10-Q Quarterly financial report (unaudited) 2026-05-05
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for SDGR. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open SDGR in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.